Scientific article
OA Policy
English

Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease

Published in

Nephrology Dialysis Transplantation, vol. 36, no. 1, p. 60-68

Publication date

2021

Abstract

Background: Nicotinamide adenine dinucleotide (NAD+) is a ubiquitous coenzyme involved in electron transport and a co-substrate for sirtuin function. NAD+ deficiency has been demonstrated in the context of acute kidney injury (AKI). Methods: We studied the expression of key NAD+ biosynthesis enzymes in kidney biopsies from human allograft patients and patients with chronic kidney disease (CKD) at different stages. We used ischaemia-reperfusion injury (IRI) and cisplatin injection to model AKI, urinary tract obstruction [unilateral ureteral obstruction (UUO)] and tubulointerstitial fibrosis induced by proteinuria to investigate CKD in mice. We assessed the effect of nicotinamide riboside (NR) supplementation on AKI and CKD in animal models. Results: RNA sequencing analysis of human kidney allograft biopsies during the reperfusion phase showed that the NAD+de novo synthesis is impaired in the immediate post-transplantation period, whereas the salvage pathway is stimulated. This decrease in de novo NAD+ synthesis was confirmed in two mouse models of IRI where NR supplementation prevented plasma urea and creatinine elevation and tubular injury. In human biopsies from CKD patients, the NAD+de novo synthesis pathway was impaired according to CKD stage, with better preservation of the salvage pathway. Similar alterations in gene expression were observed in mice with UUO or chronic proteinuric glomerular disease. NR supplementation did not prevent CKD progression, in contrast to its efficacy in AKI. Conclusion: Impairment of NAD+ synthesis is a hallmark of AKI and CKD. NR supplementation is beneficial in ischaemic AKI but not in CKD models.

Citation (ISO format)

FAIVRE, Anna et al. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease. In: Nephrology Dialysis Transplantation, 2021, vol. 36, n° 1, p. 60–68. doi: 10.1093/ndt/gfaa124

Main files (1)

Article (Published version)

Secondary files (1)

Supplemental data

Identifiers

Additional URL for this publication

https://academic.oup.com/ndt/article/36/1/60/5939791

Journal ISSN

1460-2385
621views
534downloads

Technical informations

Creation

04/02/2021 11:13:00

First validation

04/02/2021 11:13:00

Update

16/03/2023 00:02:20

Status update

16/03/2023 00:02:18

Last indexation

31/10/2024 21:16:20
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated